The genetic association between the SLC30A8 gene and the increased risk of T2DM and diabetic nephropathy (DN) was investigated, by examining the DNA methylation status of six CpG sites in the SLC30A8 promoter using blood samples. The gene discussed is SLC30A8; the disease is diabetic kidney disease.